This study will review medical records of adults with cancer who received nivolumab either as an intravenous (IV) infusion or as a subcutaneous (under the skin) injection in community oncology clinics in the United States. The study will describe who receives each type of treatment, how the treatments are used, and selected safety events such as reactions at the injection or infusion site and infections.
Study Type
OBSERVATIONAL
Enrollment
200
As per product label
As per product label
Florida Cancer Specialists & Research Institute
Fort Myers, Florida, United States
Participant age
Time frame: Baseline
Participant sex
Time frame: Baseline
Participant race
Time frame: Baseline
Participant ethnicity
Time frame: Baseline
Body mass index (kg/m²)
Time frame: Baseline
Smoking status
Time frame: Baseline
Cancer diagnosis
Time frame: Baseline
Disease stage at initial diagnosis (Stage 0-IV, unknown)
Time frame: Baseline
Eastern Cooperative Oncology Group (ECOG) performance status distribution (0-4, unknown)
Time frame: Baseline
Number of participants by tumor histology categories as applicable for each disease type, including unknown.
Time frame: Baseline
Duration of therapy (days)
Duration of therapy defined as time in days from first administration to last administration.
Time frame: Up to 6 months
Duration of planned therapy (days)
Duration of planned therapy defined as time in days from start date to last ordered treatment.
Time frame: Up to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dose administered at index (mg)
Time frame: Baseline
Concomitant anti-cancer therapy use
Number and proportion of participants receiving concomitant anti-cancer therapies (yes/no).
Time frame: Baseline
Location of injection site (thigh or abdomen)
Cohort 2
Time frame: Up to 6 months
Number of participants with treatment switches or discontinuation.
Time frame: Up to 6 months
Number of participants by education level (high school, some college, completed college, graduate school).
Time frame: Baseline
Number of participants by household income categories.
Time frame: Baseline
Number of participants by geographic classification (urban, suburban, rural).
Time frame: Baseline